Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cunningham

Showing results (161-170 of 621) with videos related to

Pageof 63
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Cardiotoxicity in patients treated with bevacizumab is potentially reversibleEliza A Hawkes, Alicia F C Okines, Chris Plummer, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 3, 2009
Inequity of access to implantable cardioverter defibrillator therapy in England: possible causes of geographical variation in implantation ratesJanet M McComb, Christopher J Plummer, Morag W Cunningham, et al.
Journal of Lipid Research|December 6, 2005
Description of the torcetrapib series of cholesteryl ester transfer protein inhibitors, including mechanism of actionRonald W Clark, Roger B Ruggeri, David Cunningham, et al.
Lancet (London, England)|November 25, 2010
Trastuzumab for gastric cancer treatmentAlicia Fc Okines, Alice Dewdney, Ian Chau, et al.
European Journal of Cancer (Oxford, England : 1990)|September 30, 2004
Sixty-day all-cause mortality rates in patients treated for gastrointestinal cancers, in randomised trials, at the Royal Marsden HospitalOurania Katopodis, Paul Ross, Andrew R Norman, et al.
Seminars in Radiation Oncology|June 8, 2011
Neoadjuvant chemotherapy alone for early-stage rectal cancer: an evolving paradigm?Eliza A Hawkes, David Cunningham, Diana Tait, et al.
Journal of Surgical Oncology|January 6, 2015
A case of metastatic pancreatic adenocarcinoma with prolonged survival after combination of neoadjuvant FOLFIRINOX therapy and synchronous distal pancreatectomy and hepatectomyKyriakos Neofytou, Alexandros Giakoustidis, Elizabeth C Smyth, et al.
BMJ (Clinical Research Ed.)|January 1, 2005
Paediatric cardiac surgical mortality after Bristol: paediatric cardiac hospital episode statistics are unreliableJohn L Gibbs, David Cunningham, Marc de Leval, et al.
Future Oncology (London, England)|March 12, 2015
Pancreatic neuroendocrine tumors: a reviewKate Young, Ridhima Iyer, Daniel Morganstein, et al.
Future Oncology (London, England)|June 22, 2022
Can we predict the progression of premalignant pancreatic cystic tumors to ductal adenocarcinoma?Swathikan Chidambaram, Michal Kawka, Tamara Mh Gall, et al.
Pageof 63

Showing results (161-170 of 621) with videos related to

Sort By:
Pageof 63
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Cardiotoxicity in patients treated with bevacizumab is potentially reversibleEliza A Hawkes, Alicia F C Okines, Chris Plummer, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 3, 2009
Inequity of access to implantable cardioverter defibrillator therapy in England: possible causes of geographical variation in implantation ratesJanet M McComb, Christopher J Plummer, Morag W Cunningham, et al.
Journal of Lipid Research|December 6, 2005
Description of the torcetrapib series of cholesteryl ester transfer protein inhibitors, including mechanism of actionRonald W Clark, Roger B Ruggeri, David Cunningham, et al.
Lancet (London, England)|November 25, 2010
Trastuzumab for gastric cancer treatmentAlicia Fc Okines, Alice Dewdney, Ian Chau, et al.
European Journal of Cancer (Oxford, England : 1990)|September 30, 2004
Sixty-day all-cause mortality rates in patients treated for gastrointestinal cancers, in randomised trials, at the Royal Marsden HospitalOurania Katopodis, Paul Ross, Andrew R Norman, et al.
Seminars in Radiation Oncology|June 8, 2011
Neoadjuvant chemotherapy alone for early-stage rectal cancer: an evolving paradigm?Eliza A Hawkes, David Cunningham, Diana Tait, et al.
Journal of Surgical Oncology|January 6, 2015
A case of metastatic pancreatic adenocarcinoma with prolonged survival after combination of neoadjuvant FOLFIRINOX therapy and synchronous distal pancreatectomy and hepatectomyKyriakos Neofytou, Alexandros Giakoustidis, Elizabeth C Smyth, et al.
BMJ (Clinical Research Ed.)|January 1, 2005
Paediatric cardiac surgical mortality after Bristol: paediatric cardiac hospital episode statistics are unreliableJohn L Gibbs, David Cunningham, Marc de Leval, et al.
Future Oncology (London, England)|March 12, 2015
Pancreatic neuroendocrine tumors: a reviewKate Young, Ridhima Iyer, Daniel Morganstein, et al.
Future Oncology (London, England)|June 22, 2022
Can we predict the progression of premalignant pancreatic cystic tumors to ductal adenocarcinoma?Swathikan Chidambaram, Michal Kawka, Tamara Mh Gall, et al.
Pageof 63